SARS-CoV-2 (Covid-19): A short update on molecular biochemistry, pathology, diagnosis and therapeutic strategies

AAA Ismail - Annals of Clinical Biochemistry, 2022 - journals.sagepub.com
The ongoing coronavirus (covid-19) pandemic highlights the need for global scientific
cooperation to advance our understanding of the immunological, molecular and biochemical …

Predicting the number of people infected with SARS-COV-2 in a population using statistical models based on wastewater viral load

JA Vallejo, S Rumbo-Feal, K Conde-Pérez… - MedRxiv, 2020 - medrxiv.org
The quantification of the SARS-CoV-2 RNA load in wastewater has emerged as a useful tool
to monitor COVID-19 outbreaks in the community. This approach was implemented in the …

The downregulation of angiotensin-converting enzyme 2 expression may be associated with depression and anxiety among patients with severe acute respiratory …

CE Okechukwu - Current Medical Issues, 2021 - journals.lww.com
ACE2 and dopa decarboxylase (DDC) co-express and co-regulate in non-neuronal cell
types.[16] Reduction in ACE2 expression may also decrease DDC expression, thus altering …

Vascular Effects of Low-Dose ACE2 Inhibitor MLN-4760—Benefit or Detriment in Essential Hypertension?

A Berenyiova, I Bernatova, A Zemancikova, M Drobna… - Biomedicines, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infects host cells through
angiotensin-converting enzyme 2 (ACE2). Concurrently, the product of ACE2 action …

[HTML][HTML] N-acetylcysteine as adjuvant therapy for hospitalized Covid-19 patients: A single-center prospective cohort study

S Afaghi, N Moghimi, NM Alamdari… - Caspian Journal of …, 2023 - ncbi.nlm.nih.gov
Background: Whilst over two years have passed since the COVID-19 pandemic's
emergence, the proper management of the disease remains challenging. N-acetylcysteine …

[HTML][HTML] Prevalence and clinical characteristics of COVID-19 in inpatients with schizophrenia in Wuhan, China

HW Sheng, HG Wang, CZ Wang, J Wu… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND In contrast to many Western countries, China has maintained its large
psychiatric hospitals. The prevalence and clinical characteristics of coronavirus disease …

The COSEVAST Study: Unravelling the role of arterial stiffness in COVID-19 disease severity

S Kumar, N Kumar, A Kumar, D Bhushan, A Kumar… - medRxiv, 2020 - medrxiv.org
Background Based on the detailed review of available research and case studies reported
in reputed international journals, it can be concluded that endothelial damage (En …

Quercetin may reduce the risk of developing the symptoms of COVID-19.

M Ajami, M Sotoudeheian… - Avicenna Journal of …, 2024 - search.ebscohost.com
Objective: Recent evidence reported that some dietary compounds like quercetin and
apigenin as the most well-known flavonoids with anti-inflammatory effects may inhibit SARS …

SARS-CoV-2 and interferon blockade

B Diamond, BT Volpe, S VanPatten, Y Al Abed - Molecular Medicine, 2020 - Springer
The response to viral infection generally includes an activation of the adaptive immune
response to produce cytotoxic T cells and neutralizing antibodies. We propose that SARS …

The High Pressure of Fighting the COVID-19 Pandemic

IBSS Costa, HB Zampa - Arquivos Brasileiros de Cardiologia, 2021 - SciELO Brasil
Although we have been facing the challenges posed by the new coronavirus for almost two
years, we still have a long way to go. The rapid and easy spread of the virus not only worries …